189 related articles for article (PubMed ID: 31518641)
1. Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls.
Vlot AHC; Aniceto N; Menden MP; Ulrich-Merzenich G; Bender A
Drug Discov Today; 2019 Dec; 24(12):2286-2298. PubMed ID: 31518641
[TBL] [Abstract][Full Text] [Related]
2. An integrated framework for identification of effective and synergistic anti-cancer drug combinations.
Sharma A; Rani R
J Bioinform Comput Biol; 2018 Oct; 16(5):1850017. PubMed ID: 30304987
[TBL] [Abstract][Full Text] [Related]
3. Methods for High-throughput Drug Combination Screening and Synergy Scoring.
He L; Kulesskiy E; Saarela J; Turunen L; Wennerberg K; Aittokallio T; Tang J
Methods Mol Biol; 2018; 1711():351-398. PubMed ID: 29344898
[TBL] [Abstract][Full Text] [Related]
4. Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets.
Amzallag A; Ramaswamy S; Benes CH
BMC Bioinformatics; 2019 Feb; 20(1):83. PubMed ID: 30777010
[TBL] [Abstract][Full Text] [Related]
5. Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
Österroos A; Kashif M; Haglund C; Blom K; Höglund M; Andersson C; Gustafsson MG; Eriksson A; Larsson R
Biochem Pharmacol; 2016 Oct; 118():40-49. PubMed ID: 27565890
[TBL] [Abstract][Full Text] [Related]
6. Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis.
Varbanov HP; Kuttler F; Banfi D; Turcatti G; Dyson PJ
PLoS One; 2019; 14(1):e0211268. PubMed ID: 30695050
[TBL] [Abstract][Full Text] [Related]
7. Mind the Curve: Dose-Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies.
Fuentealba-Manosalva O; Mansilla M; Buelvas N; Martin-Martin A; Torres CG; López-Muñoz RA
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298656
[TBL] [Abstract][Full Text] [Related]
8. In silico drug combination discovery for personalized cancer therapy.
Jeon M; Kim S; Park S; Lee H; Kang J
BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
[TBL] [Abstract][Full Text] [Related]
9. A pragmatic definition of therapeutic synergy suitable for clinically relevant in vitro multicompound analyses.
Kashif M; Andersson C; Åberg M; Nygren P; Sjöblom T; Hammerling U; Larsson R; Gustafsson MG
Mol Cancer Ther; 2014 Jul; 13(7):1964-76. PubMed ID: 24755197
[TBL] [Abstract][Full Text] [Related]
10. A generalized response surface model with varying relative potency for assessing drug interaction.
Kong M; Lee JJ
Biometrics; 2006 Dec; 62(4):986-95. PubMed ID: 17156272
[TBL] [Abstract][Full Text] [Related]
11. Detecting bliss synergy in in vivo combination studies with a tumor kinetic model.
Zhao W; Vicini P; Novick S; Anderton J; Davies G; DAngelo G; O'Day T; Yu B; Harper J; Narwal R; Roskos L; Yang H
Pharm Stat; 2019 Nov; 18(6):688-699. PubMed ID: 31140720
[TBL] [Abstract][Full Text] [Related]
12. SNSynergy: Similarity network-based machine learning framework for synergy prediction towards new cell lines and new anticancer drug combinations.
Huangfu X; Zhang C; Li H; Li S; Li Y
Comput Biol Chem; 2024 Jun; 110():108054. PubMed ID: 38522389
[TBL] [Abstract][Full Text] [Related]
13. Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism.
Kashif M; Andersson C; Mansoori S; Larsson R; Nygren P; Gustafsson MG
Oncotarget; 2017 Nov; 8(61):103952-103967. PubMed ID: 29262612
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreen.
Perez DR; Edwards BS; Sklar LA; Chigaev A
SLAS Discov; 2018 Aug; 23(7):751-760. PubMed ID: 29842834
[TBL] [Abstract][Full Text] [Related]
15. A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.
Palmer AC; Chidley C; Sorger PK
Elife; 2019 Nov; 8():. PubMed ID: 31742555
[TBL] [Abstract][Full Text] [Related]
16. Network Propagation Predicts Drug Synergy in Cancers.
Li H; Li T; Quang D; Guan Y
Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
[TBL] [Abstract][Full Text] [Related]
17. You Cannot Have Your Synergy and Efficacy Too.
Sen P; Saha A; Dixit NM
Trends Pharmacol Sci; 2019 Nov; 40(11):811-817. PubMed ID: 31610891
[TBL] [Abstract][Full Text] [Related]
18. CombiTool--a new computer program for analyzing combination experiments with biologically active agents.
Dressler V; Müller G; Sühnel J
Comput Biomed Res; 1999 Apr; 32(2):145-60. PubMed ID: 10337496
[TBL] [Abstract][Full Text] [Related]
19. Parallel dose-response curves in combination experiments.
Sühnel J
Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput yeast assay identifies synergistic drug combinations.
Torres NP; Lee AY; Giaever G; Nislow C; Brown GW
Assay Drug Dev Technol; 2013 Jun; 11(5):299-307. PubMed ID: 23772551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
